Pegvaliase Completed Phase 1 Trials for Phenylketonuria (PKU) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00634660Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria